AngioDynamics ANGO Deferred Tax and Other Liabilities (Non-Current)
Deferred Tax and Other Liabilities (Non-Current) at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's deferred tax and other liabilities (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's deferred tax and other liabilities (non-current)?
- AngioDynamics (ANGO) reported deferred tax and other liabilities (non-current) of $4.55M in Q4 2025.
- How has AngioDynamics's deferred tax and other liabilities (non-current) changed year-over-year?
- AngioDynamics's deferred tax and other liabilities (non-current) increased by 8.4% year-over-year, from $4.2M to $4.55M.
- What is the long-term trend for AngioDynamics's deferred tax and other liabilities (non-current)?
- Over 4 years (2021 to 2025), AngioDynamics's deferred tax and other liabilities (non-current) has grown at a -32.8% compound annual growth rate (CAGR), from $19.96M to $4.07M.